Numerous studies have reported elevated platelet activation markers, such as P-selectin, CD40L, and platelet-leukocyte aggregates, in MPN, with some demonstrating a correlation between platelet activation and clinical thrombosis [44, 45]. This evidence concerns the gene SELP and myeloproliferative disorder.